<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000508532"><TermName>Xeloda</TermName><TermPronunciation>(zeh-LOH-duh)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat stage III colon cancer in patients who had surgery to remove the cancer. It is also used to treat metastatic breast cancer that has not improved after treatment with certain other anticancer drugs. Xeloda is being studied in the treatment of other types of cancer. It is taken up by cancer cells and breaks down into 5-fluorouracil, a substance that kills tumor cells. Xeloda is a type of antimetabolite. Also called capecitabine.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718224" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Xeloda&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718223" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Xeloda&quot;" language="es" id="_4"/><SpanishTermName>Xeloda</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar el cáncer de colon en estadio III en pacientes que se sometieron a cirugía para extirpar el cáncer. Asimismo, se usa para tratar el cáncer metastásico de mama que no ha mejorado después del tratamiento con otros medicamentos contra el cáncer. Xeloda está en estudio para el tratamiento de otros tipos de cáncer. Cuando las células cancerosas la absorben, se descompone en fluorouracilo-5, una sustancia que destruye las células tumorales. Xeloda es un tipo de antimetabolito. También se llama capecitabina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-09-15</DateFirstPublished><DateLastModified>2007-11-30</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000496354">Capecitabine</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
